Did Novo Nordisk executive faint in Oval Office? Company clarifies amid buzz about Gordon Findlay

Man Faints During Oval Office Press Conference

During a White House press conference on Thursday, a man fainted in the Oval Office. President Donald Trump was announcing a deal with drugmakers aimed at lowering the cost of obesity drugs when the incident occurred. A video showing the man collapsing circulated widely online.

Eyewitness and Public Reactions

Independent journalist Eric Daugherty shared the video, stating,

“A man just passed out during President Trump’s Oval Office announcement. Oz SPRUNG into action and assisted him.”
He also urged,
“Pray for him.”
Many viewers expressed concern and shared prayers for the man's recovery despite the live feed being cut short.

Clarification About the Man's Identity

The man was initially identified as Gordon Findlay and was widely reported to be a Novo Nordisk executive. One social media account claimed,

“BREAKING: Novo Nordisk executive Gordon Findlay collapses during Trump's announcement in Oval Office, announcement suspended.”

However, Novo Nordisk clarified that the individual was not affiliated with their company. They stated to Newsweek,

“CEO Mike Doustdar and EVP, US Operations, Dave Moore were the only two Novo Nordisk representatives in the Oval Office. We hope the gentleman who suffered a medical incident today is okay.”

White House Statement on the Incident

Press Secretary Karoline Leavitt explained,

“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted.”

Summary

The man who fainted in the Oval Office during President Trump's obesity drug cost announcement was not a Novo Nordisk executive, according to company and White House statements.

Author’s summary: A man fainted during a White House announcement on obesity drug pricing, stirring concerns and clarifications about his identity and company affiliation.

more

Hindustan Times Hindustan Times — 2025-11-06

More News